SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,532,901 | -13.8% | 74,485 | +96.8% | 0.00% | 0.0% |
| Q2 2023 | $1,779,330 | +445.2% | 37,842 | +386.5% | 0.00% | – |
| Q1 2023 | $326,364 | -81.3% | 7,778 | -83.0% | 0.00% | -100.0% |
| Q4 2022 | $1,745,705 | +403.1% | 45,771 | +417.0% | 0.00% | – |
| Q3 2022 | $347,000 | -98.8% | 8,854 | -99.0% | 0.00% | -100.0% |
| Q1 2022 | $27,958,000 | -19.0% | 844,652 | +4.1% | 0.03% | -14.7% |
| Q4 2021 | $34,518,000 | +32.3% | 811,434 | +37.8% | 0.03% | +21.4% |
| Q3 2021 | $26,100,000 | +11.8% | 589,039 | +43.4% | 0.03% | +12.0% |
| Q2 2021 | $23,335,000 | +24.8% | 410,753 | +64.4% | 0.02% | +8.7% |
| Q1 2021 | $18,704,000 | +29.3% | 249,888 | +49.5% | 0.02% | +21.1% |
| Q4 2020 | $14,461,000 | – | 167,157 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |